Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients.
about
Unfaithful neurotransmitter transporters: focus on serotonin uptake and implications for antidepressant efficacyThe Involvement of Genes in Adolescent Depression: A Systematic ReviewPharmacology of serotonin and female sexual behaviorFrom psychiatric disorders to animal models: a bidirectional and dimensional approachCognitive mechanisms of treatment in depressionFrom pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatmentNovel Primate Model of Serotonin Transporter Genetic Polymorphisms Associated with Gene Expression, Anxiety and Sensitivity to Antidepressants.Study protocol for a randomized controlled trial to explore the effects of personalized lifestyle advices and tandem skydives on pleasure in anhedonic young adults.Genetic prediction of antidepressant drug response and nonresponse in Korean patientsAssociations of 5HTTLPR polymorphism with major depressive disorder and alcohol dependence: A systematic review and meta-analysis.Optogenetic control of serotonin and dopamine release in Drosophila larvae.Quantitative evaluation of serotonin release and clearance in Drosophila.Human amygdala volume is predicted by common DNA variation in the stathmin and serotonin transporter genesVulnerability to lasting anxiogenic effects of brief exposure to predator stimuli: sex, serotonin and other factors-relevance to PTSD.Genetic variation in cortico-amygdala serotonin function and risk for stress-related diseaseConvergent animal and human evidence suggests the activin/inhibin pathway to be involved in antidepressant responseThe influence of 5-HTTLPR genotype on the association between the plasma concentration and therapeutic effect of paroxetine in patients with major depressive disorder.Towards the clinical implementation of pharmacogenetics in bipolar disorder.Pharmacogenetics of major depression: insights from level 1 of the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial.Association between serotonin transporter polymorphisms (5-HTTLPR) and the MADRS Dysphoria, Retardation, and Vegetative Subscale scores in the treatment of depressionThe influence of psychiatric screening in healthy populations selection: a new study and meta-analysis of functional 5-HTTLPR and rs25531 polymorphisms and anxiety-related personality traits.How possible is the development of an operational psychometric method to assess the presence of the 5-HTTLPR s allele? Equivocal preliminary findingsSerotonin transporter triallelic genotype and response to citalopram and risperidone in dementia with behavioral symptoms.A serotonin transporter gene polymorphism predicts peripartum depressive symptoms in an at-risk psychiatric cohortAntidepressant response and the serotonin transporter gene-linked polymorphic regionOverview of the genetics of major depressive disorderPharmacogenetics of antidepressant response.Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy.Effects of BDNF polymorphisms on antidepressant action.Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines.Neonatal pain and COMT Val158Met genotype in relation to serotonin transporter (SLC6A4) promoter methylation in very preterm children at school age.Childhood stress, serotonin transporter gene and brain structures in major depression.Affective cognition and its disruption in mood disorders.Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatmentDifferential effects of 5-HTTLPR genotypes on inhibition of negative emotional information following acute stress exposure and tryptophan challenge.Relation of serotonin transporter genetic variation to efficacy of escitalopram for generalized anxiety disorder in older adultsPharmacogenetics of antidepressantsGenome-wide association studies of antidepressant outcome: a brief review.A double-blind, randomized trial of sertraline for alcohol dependence: moderation by age of onset [corrected] and 5-hydroxytryptamine transporter-linked promoter region genotype.Ontogeny and regulation of the serotonin transporter: providing insights into human disorders.
P2860
Q24658095-6FC3A41D-6057-49B5-B83D-DE31F4D6A30CQ26770741-E4756E34-1B2E-4CE3-80A4-CB1A9844FE90Q26861672-8D3BE42F-4CE5-42A1-88DB-4A7E2691809AQ26996269-D95FF032-3A6A-4674-B7BA-675EFBAF5256Q27001088-5158156A-F580-47C0-9F02-D8BAC0432356Q27015830-61BF6FF3-882C-467B-B0E0-90890E2006BFQ27310483-4E828CCD-FBF3-4AEB-8027-9A8092EB2697Q27311033-E8FC8090-F438-4E58-9C54-A4B862D434C2Q28543005-2DF818D8-A09F-4E63-AFEA-6B28E923C00CQ30251779-D1D5FF57-7BA5-417D-9D1E-E57E376C9BE6Q30371354-7A2B2EC0-92F3-4368-B143-1D9D57C82630Q30436140-61517DBB-C5D2-4387-A6EB-F163CB89AE36Q30451308-90BE874D-54EA-4474-9D57-133D7765B257Q30487275-2BDC35DA-F11D-41A7-A071-6B3609431B49Q30487278-5A519975-1954-4906-9D58-7BA52ABBA83BQ30534765-10A34219-F726-4E97-BE99-B9308937087CQ33654737-9AC9676D-FE0A-4161-A39C-9381BA52F872Q33688133-3469723C-ADC1-4409-BC13-0BB1624ECC9CQ33730306-C309A80F-692F-4B8B-A455-877A79AD2C9EQ33806771-A7E9BB45-A1FE-4757-934D-0DAF4CDA7322Q33858787-B83C4069-6BBB-488C-84BF-A00232C451EBQ33892493-840888B6-1934-4DEE-93D5-0401B8AEAF31Q33921338-CE7C8317-FE98-4BD0-AD11-E93B48C00E9AQ33940182-C0FF217A-7546-4287-85FE-FDA5662A6157Q34088515-CD3FFC55-DE30-4F31-B926-00F334E8219DQ34138509-B85A4AA2-BBC5-4764-B6D9-CF2FFA532205Q34155796-15F68ACE-C619-4031-BA3A-CC91451275CEQ34316695-879ED260-9761-4E5C-A3D4-997FC50B8BFBQ34497530-2B6B768D-3FFC-4A85-8976-3394753B1F2CQ34590507-514436A6-BAE1-4724-BE9E-6C23A9665696Q34608922-B43A5379-D5A8-4438-BCB3-EB4B2E8D6431Q34660587-67CCF6F1-3017-47E4-AB20-71B476666A37Q34661207-26E46FEF-9495-44AC-BE42-FAE2D47A8557Q34661625-4C384539-2518-4173-B5B4-9800BD6C12BCQ34662062-E0947FE2-59F8-4860-A925-896C8D770E35Q34685706-457AA822-998B-4142-A040-C6674BF54B05Q35026088-DE99BA37-6F34-4C21-BB81-FD038334A2B9Q35074796-93A719A4-B386-48B5-9C2A-C83058C9D195Q35088135-8ACBDE53-D9F1-46BF-A638-7C3403B811DBQ35090255-06C04F82-A625-4F10-A3BD-9B6818DB8DDD
P2860
Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Meta-analysis of serotonin tra ...... fficacy in depressed patients.
@ast
Meta-analysis of serotonin tra ...... fficacy in depressed patients.
@en
type
label
Meta-analysis of serotonin tra ...... fficacy in depressed patients.
@ast
Meta-analysis of serotonin tra ...... fficacy in depressed patients.
@en
prefLabel
Meta-analysis of serotonin tra ...... fficacy in depressed patients.
@ast
Meta-analysis of serotonin tra ...... fficacy in depressed patients.
@en
P2093
P356
P1433
P1476
Meta-analysis of serotonin tra ...... fficacy in depressed patients.
@en
P2093
P2888
P304
P356
10.1038/SJ.MP.4001926
P407
P577
2006-12-05T00:00:00Z
P5875
P6179
1032014011